By Devika Patel
Knoxville, Tenn., Oct. 14 - Fibrocell Science, Inc. took in $3.25 million in a private placement of its series A convertible preferred stock on Oct. 13, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company sold 3,250 preferreds at $1,000.00 per preferred.
Investors also received class A warrants for 501,543 common shares, which are exercisable at $1.62 per share, and class B warrants for 416,667 common shares, which are exercisable at $1.95 per share.
Each 6% preferred is convertible into common shares at a conversion price of $1.30 per share.
Viriathus Capital LLC and John Carris Investments LLC were co-placement agents.
Fibrocell is a based in Exton, Pa.
| Issuer: | Fibrocell Science, Inc.
|
| Issue: | Series A convertible preferred stock
|
| Amount: | $3.25 million
|
| Shares: | 3,250
|
| Price: | $1,000.00
|
| Dividends: | 6%
|
| Conversion price: | $1.30
|
| Warrants: | For 918,210 shares
|
| Warrant strike price: | $1.62 (class A), $1.95 (class B)
|
| Agents: | Viriathus Capital LLC and John Carris Investments LLC
|
| Settlement date: | Oct. 13
|
| Stock symbol: | Pink Sheets: FCSC
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
